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Abstract 
Melanin synthesis in the mouse involves the interaction of many pigmentation loci. Tyrosinase, the product of the albino (c) locus, 
catalyses the first step of the pathway. The brown (b) locus protein has significant homology to tyrosinase and controls black/brown coat 
coloration, but its function is controversial. To investigate the function of the b-protein and its interaction with tyrosinase, we established 
cell lines expressing both tyrosinase and the b-protein by transfecting tyrosinase-expressing f broblasts with a b-protein expression vector. 
The tyrosinase-expressing parent line does not have L-dopachrome tautomerase activity, but this enzyme is detectable in double 
transfectants a well as in fibroblasts expressing the b-protein alone. Cells expressing both proteins have a higher steady-state level of 
tyrosinase than fibroblasts expressing tyrosinase alone, and contain elevated levels of melanin intermediates. This is thought to result from 
interaction of tyrosinase with the b-protein. Only phaeomelanin is detectable in fibroblasts expressing tyrosinase alone, whereas double 
transfectants synthesise significantly more phaeomelanin a d detectable eumelanin. 
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1. Introduction 
Pigment synthesis requires the interaction of a large 
number of proteins, many of which are expressed only by 
melanocytes. Over the past nine years the genes encoding 
several of these proteins have been cloned from the mouse, 
and this has greatly improved our understanding of their 
phenotypic effects [1-3]. Protein products of the albino, 
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brown and slaty loci have been shown to function as 
melanogenic enzymes [4-12], whereas the silver locus 
protein may be a structural component of melanosomes, 
the specialised membrane-bound organelles in which pig- 
ment is synthesised [13,14]. The product of the pink-eyed 
dilution locus appears likely to act as an integral mem- 
brane transporter protein [15] and the extension locus 
protein is the melanocyte r ceptor for a-melanocyte stimu- 
lating hormone [16]. 
Expression and purification studies have been used to 
study individual cloned melanogenic enzymes. However, 
this is unlikely to give a true picture of their functions in 
vivo since several of the enzymes involved in melanin 
synthesis appear to be organised in a high molecular 
weight complex in the melanosomal membrane, and this is 
very likely to influence their activities [2,17,18]. We have 
previously used a mouse fibroblast expression system to 
study the functions of the proteins encoded at the albino 
(c) locus and brown (b) locus in isolation [12,19]. Both 
proteins are located in lysosomes in transfected fibroblasts, 
a finding consistent with recent evidence that melanosomes 
are closely related to lysosomes [17,20]. The aim of this 
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study was to express both proteins simultaneously in fi- 
broblasts to determine whether co-expression i fluences 
the function of either protein, and the phenotype of the 
cells. 
The product of the albino locus is the enzyme tyrosi- 
nase (EC 1.14.18.1) which catalyses the first two steps of 
the melanin synthesis pathway, the hydroxylation of L- 
tyrosine to L-dopa and the oxidation of L-dopa to 
dopaquinone. It is the key enzyme in melanin synthesis 
and in null mutants no pigment is formed. In the presence 
of cysteine or other thiols, dopaquinone enters the pathway 
of phaeomelanogenesis [21,22], and fibroblasts transfected 
with a mouse tyrosinase cDNA have been shown to syn- 
thesise a phaeomelanic pigment [19]. 
If the supply of thiols is restricted, dopaquinone oxi- 
dises to dopachrome which, in turn undergoes oxidative 
decarboxylation to form 5,6-dihydroxyindole (DHI). How- 
ever, the enzyme dopachrome tautomerase (EC 5.3.2.3) or 
specific metal ions direct the tautomerisation of 
dopachrome to the carboxylated indole 5,6-dihydroxyin- 
dole-2-carboxylic a id (DHICA) [18,23-27]. In the mouse, 
both the brown locus protein (b-protein or TRP-1) and the 
slaty locus protein (TRP-2) have been shown to possess 
dopachrome tautomerase activity in vitro [11,12]. 
The wild-type b-protein has a clear phenotypic effect 
converting the brown mouse coat colour to black, but its 
precise function is still controversial. In addition to acting 
as a dopachrome tautomerase, evidence has been published 
that it functions as a second tyrosinase [6,7] or as a 
melanocyte-specific catalase [28]. We were, however, un- 
able to detect either of these activities in fibroblasts ex- 
pressing the b-protein in isolation, and these cells do not 
synthesise melanin [12]. Recently, the b-protein has been 
shown to be capable of oxidising DHICA in vitro [29] and 
hence may be involved in polymerisation of indoles to 
form eumelanin. Tyrosinase may also have a role in this 
process as it is able to oxidise DHI [30,31] and peroxidase 
has also been implicated [:22,32]. By analysing enzyme 
activities and melanin intermediates in fibroblasts co-ex- 
pressing tyrosinase and the b-protein, our aim was to gain 
further insight into the precise roles of these two enzymes 
in the complex process of melanin synthesis. 
2. Materials and methods 
2.1. Chemicals 
All cell culture reagents were purchased from Gibco 
(Paisley, UK). PBSA tablets were obtained from Oxoid 
(Basingstoke, UK). Con A-Sepharose was from Pharmacia 
(Uppsala, Sweden) and araido black was from Sebia. 
Bovine serum albumin, 3,3'-diaminobenzidine, dithio- 
threitol, G418, hydrogen peroxide, hygromycin B, NP-40, 
SDS, Triton X-100 and Tween 20 were purchased from 
Sigma (Poole, UK), as were prestained molecular mass 
markers for polyacrylamide g l electrophoresis. Perchloric 
acid was obtained from BDH (Poole, UK). All other 
reagents were of analytical grade. 
2.2. Antibodies 
Mouse monoclonal antibody TA99 [33] used in 
immunofluorescence was a gift from Dr K.O. Lloyd 
(Sloan-Kettering Cancer Center, New York, USA). The 
commercially available form of TA99 (MEL-5) was used 
in Western blotting (Signet Laboratories, Dedham, USA). 
Rabbit polyclonal antibodies a PEP5 and c~PEP7 [34] 
were provided by Dr V.J. Hearing (NIH, Bethesda, USA). 
HRP-conjugated goat anti-mouse IgG was purchased from 
Bio-Rad (Hemel Hempstead, UK). 125I-labelled goat anti- 
rabbit and rabbit anti-mouse second antibodies were a gift 
from Dr M.E. Bramwell (Sir William Dunn School of 
Pathology, University of Oxford, UK). 
2.3. Cell culture 
3T3 Swiss mouse fibroblasts were grown in DMEM 
supplemented with 10% (v/v)  foetal calf serum and 2 mM 
L-glutamine. Clone c, a line of 3T3 Swiss fibroblasts 
expressing mouse c locus tyrosinase, has been described 
previously [19,35], as have line pKG4 (transfected with a 
G418-resistance g ne) [19] and fibroblasts expressing the 
mouse b-protein (subclones bl. 2, b2.1 and b2. 2) [12]. These 
transfected lines were cultured in the above medium sup- 
plemented with 0.8 mg ml -l G418. All lines were pas- 
saged by incubation (37°C for 5 min) in 
PBSA/EDTA/trypsin (PBSA containing 0.02% (w/v)  
EDTA and 0.125% (w/v) trypsin) and incubated in a 5% 
CO 2 humidified atmosphere. Mycoplasma tests were done 
routinely and were always negative. 
2.4. Transfection 
Clone c cells (8 × 106) were seeded in medium without 
G418 into a 175 cm 2 Nunc tissue culture flask (Gibco) 
24 h before transfection. A calcium phosphate DNA co- 
precipitate containing 18 /zg pHDMT4 [8] and 2 ~g 
pBabehygro [36] was added to the culture medium and the 
cells were incubated at 37°C for 5-7 h before treatment 
with glycerol [37]. In control flasks, clone c was trans- 
fected with 20 /zg pBabehygro alone. Fresh medium lack- 
ing antibiotics was added 24 h after transfection and 
selection with hygromycin B (0.175 mg ml- l )  was started 
24 h later. Clones were picked after 2-3 weeks. 
2.5. Sample preparation 
Method A: Cells were harvested using trypsin and 
washed twice in PBSA then resuspended in 4 volumes of 
buffer A (20 mM KH2PO 4 [pH 7.5], 0.5% (v/v)  Triton 
X-100). Lysates were sonicated for 10 s (MSE Ultrasonic 
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Disintegrator model 7100, setting 5 /xm) then centrifuged 
(9000 X g for 5 min at 4°C). The centrifugation step was 
repeated using the supernatant, and the final supernatant 
was stored in aliquots at -70°C. 
Method B: Cells were harvested and washed as in 
method A, then cell pellets were frozen in solid 
CO2/ethanol. Approximately 10 volumes of Millipore- 
purified water were added to each pellet, the suspensions 
were centrifuged (2000 × g for 10 min), and the water 
poured off. Pellets were resuspended in approximately 10 
volumes of buffer B (50 mM KH2PO 4 [pH 7.2]) and 
homogenised by 10 strokes of an all-glass Potter-Elvehjem 
homogenizer. 
Method C: Cells were harvested and washed as in 
method A, then cell pellets were frozen in solid 
CO2/ethanol. Extracts were prepared by resuspending pel- 
lets in approximately ten volumes of Milli-Q-purified wa- 
ter for melanin determination, and 10 volumes of 0.4 M 
perchloric acid for catechol determination. 
Method D: For analysis of cell culture medium, cells 
were seeded at a fixed density of 2 × 10 6 cells per 25 cm 2 
tissue culture flask in 5 ml of medium. Representative 
flasks were taken at time points and the medium aspirated 
then centrifuged (350 x g for 3 min) to remove cell debris. 
Aliquots of the supernatant were immediately frozen in 
solid COz/ethanol and stored at -70°C. 
2.6. Enzyme assays 
Dopachrome tautomerase: Dopachrome tautomerase ac- 
tivity was determined by measuring the formation of 
DHICA and/or DHI from L-or D-dopachrome by HPLC. 
Preparation of Con A-binding fractions and dopachrome 
tautomerase assays were done as described previously [ 12]. 
Tyrosinase: The tyrosine hydroxylase activity of tyrosi- 
nase was determined using the 14CO2 assay [38], and the 
dopa oxidase activity of tyrosinase was measured using 
both the continuous and stopped MBTH assays [38,39] in 
extracts prepared by method A. In addition, dopa oxidase 
activity was determined by measuring the formation of 
L-5-S-cysteinyldopa from L-dopa and L-cysteine in extracts 
prepared by method B, and in culture medium prepared by 
method D [40,41 ]. 
2.7. Protein determination 
Protein concentrations were determined either by using 
a protein assay kit (Bio-Rad) based on the method of 
Bradford [42] or by the method of Lowry et al. [43]. 
Bovine serum albumin was used as a reference standard. 
2.8. Growth curves 
Growth curves were determined as described previously 
[19]. All cell lines were cultured in medium plus penicillin 
and streptomycin (both at 50 /xg m1-1) but without G418 
or hygromycin B. At 24-48 h intervals cells were counted, 
pigmentation scored on an arbitrary scale as previously 
detailed [19], and extracts were prepared by method A then 
stored in aliquots at -20°C. 
2.9. SDS-polyacrylamide g l electrophoresis and Western 
blotting 
SDS-PAGE using 7.5% to 20% gradient gels and West- 
ern blotting were done as previously described [12] except 
that for gels run under reducing conditions 20 mM dithio- 
threitol was added to the sample buffer. Membranes were 
treated for 30 min with 1% (v/v)  newborn calf serum in 
PBSA containing 0.2% (v/v)  Tween 20 and 0.4 M NaC1 
(buffer C), rinsed in buffer C, and incubated at room 
temperature for 30 min with primary antibody diluted in 
buffer C (1:150, by vol. for TA99; 1:50, by vol. for 
a PEP5 and c~ PEP7). 
After washing in buffer C for 30 min, membranes were 
incubated with second antibody diluted in PBSA. The 
HRP-conjugated second antibody was diluted 1:600 (by 
vol.) and after incubation for 30 min at room temperature 
membranes were washed briefly in buffer C, rinsed in 
PBSA then incubated with 0.5 mg ml -~ 3,3'-diamino- 
benzidine plus 0.15% (w/v)  hydrogen peroxide in PBSA. 
The reaction was terminated by washing with water, and 
the membranes were dried and stored in the dark at room 
temperature until photographed. 
I-Labelled second antibodies were diluted 1:300 (by 
vol.) and after incubation for 30 min at room temperature 
membranes were washed thoroughly in buffer C (five 
changes over 30 min) and rinsed twice in PBSA. Mem- 
branes were stained with amido black then air-dried, 
wrapped in Saran wrap, and exposed to X-ray film at 
-70°C for 2-7 days. The amount of protein in specific 
bands was quantitated using an LKB Ultroscan laser den- 
sitometer. 
2.10. Analysis of  catechols, indoles and melanin 
Catechols: Cell extracts were prepared by method C 
and media samples by method D. The amounts of L-dopa, 
5-S-cysteinyldopa, 5-S-glutathionyldopa nd 5-S- 
cysteinylglycinedopa were determined by HPLC and elec- 
trochemical detection [44,45]. The detection limit for all 
four catechols is 1 pmol. 
lndoles: Media samples prepared by method D were 
analysed for the presence of indoles by HPLC methods 
described previously [46,47]. Standards were kindly pro- 
vided by Prof. G. Prota (Dept. of Organic Chemistry, 
University of Naples, Italy). 
Melanin: Cell extracts were prepared by method C for 
phaeomelanin determination. The insoluble pellet was sub- 
jected to reductive degradation i hydriodic acid and the 
hydrolysis product AHP measured as described by Ito and 
Fujita [48]. The relative quantities of eumelanin and 
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phaeomelanin were determined by measuring the yields of 
PTCA and TDCA on oxidation with potassium perman- 
ganate. The TDCA/PTCA ratio correlates with the ratio of 
phaeomelanin to eumelanin 1149]. 
2.11. Statistical analysis 
Mean values were compared using Student's t-test, 
adopting 95% confidence inllervals. 
3. Results 
3.1. Co-expression of tyrosinase and the b-protein 
To investigate interactions between tyrosinase and the 
b-protein we transfected mouse fibroblasts expressing 
mouse c locus tyrosinase [19,35] with a b-protein expres- 
sion vector. Clone c is a stable tyrosinase-expressing li e
established by co-transfection f 3T3 Swiss mouse fibrob- 
lasts with the tyrosinase xpression vector pHDmcTyrl [8] 
and a plasmid conferring resistance to G418, and was 
chosen for a second round of transfections because it 
contains a single integrated copy of the tyrosinase cDNA 
[19]. Clone c was co-transfected with the b-protein expres- 
sion vector pHDMT4 [8] and a hygromycin-resistance 
plasmid; a second selectable marker being necessary be- 
cause clone c is G418-resistant. As a control, clone c was 
transfected with the hygromycin-resistance plasmid alone. 
Clones were screened for expression of the b-protein by 
indirect immunofluorescence staining with monoclonal an- 
tibody TA99, as described previously [12]. Antibody TA99 
is specific for the b-protein [28,33] and does not stain 
untransfected fibroblasts or fibroblasts expressing tyrosi- 
nase alone, but does stain double transfectants expressing 
the b-protein (data not shown). Double transfectant lines 
are termed c + b clones since they have been transfected 
with both mouse c locus tyrosinase and the mouse b locus 
protein. In 6 clones (c + b I to c + b 6) more than 70% of 
cells reacted with antibody TA99, but these clones were 
somewhat heterogeneous and were subcloned to obtain 
homogeneous cell lines. Subclones derived from the origi- 
nal line c + b I are termed subclone c + bL,, c + b~. 2 etc., 
and notation is similar for other lines. 
A correlation was observed between pigmentation and 
expression of the b-protein. Lines isolated by transfection 
of clone c with the hygromycin-resistance gene alone 
(denoted subclone c-hygLl, c-hygl. 2 etc.) were a similar 
light brown colour to the parent cell line, but transfectants 
expressing the b-protein were distinctly darker. Production 
of pigment by double transfectant clones indicates that 
they have retained a functional c locus tyrosinase since 
this is the rate-limiting enzyme for pigment synthesis. The 
darker pigmentation of c + b clones suggests that the 
b-protein they synthesise is functional since the wild-type 
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Fig. 1. Western blot analysis of steady-state levels of (A) tyrosinase and 
(B) the b-protein. Cell extracts (80 /xg protein) from untransfected 
fibroblasts (Sw), fibroblasts expressing mouse c locus tyrosinase (clone 
c), double transfectants expressing both tyrosinase and the b-protein 
(subclones c + b l.t and c + b 1.3), and fibroblasts expressing the b-protein 
alone (subclones b]. 2 and b2A) were separated by SDS-PAGE under 
reducing conditions (A) or non-reducing conditions (B). Samples were 
blotted to nitrocellulose then probed with (A) antibody aPEP7 which 
detects membrane-bound tyrosinase or (B) antibody TA99 which detects 
the b-protein, followed by ~25I-labelled second antibodies. Arrowheads 
indicate (A) tyrosinase and (B) the b-protein. 
b-protein converts the brown mouse coat colour phenotype 
to black. 
Expression of both tyrosinase and the b-protein by 
c + b subclones was confirmed by Western blot analysis 
(Fig. 1). Antibody a PEP7 was raised against a C-terminal 
peptide of tyrosinase and recognises only the membrane- 
bound form of the enzyme [34,41,50]. Using this antibody, 
the steady-state l vel of tyrosinase was found to be 2-to 
3-fold higher in several c + b subclones than in clone c 
from which they were derived (Fig. 1A and Table 1). A 
similar result was obtained using antibody a PEP5 which 
recognises the N-terminus of the protein [34] and detects 
both membrane-bound and soluble forms of tyrosinase 
(data not shown). The level of b-protein detected with the 
highly-specific antibody TA99 was 4-to 6-fold greater in 
several c + b subclones than in lines expressing the b-pro- 
tein alone (Fig. 1B). Increased steady-state l vels of both 
proteins are thought o result from interaction of tyrosinase 
and the b-protein in a complex which enhances their 
stability [29]. 
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Table 1 
Correlation of tyrosine hydroxylase and dopa oxidase activities of trans- 
fected fibroblasts with the amount of membrane-bound tyrosinase protein 
Cell line Enzyme activity Tyrosinase protein 
(nmol min-I mg-  ~ + S.D.) (A.U. ~ -+ S.D.) 
TH DO 
Clone c 0.78+0.14 3.10_+0.10 8.3+0.4 
Subclone c+bl 1 4.64+0.59 26.28_+2.66 26.5+1.6 
Subclone c+bL3 n.d. b 17.07--+0.52 21.4-+ 1.1 
Subclone c+bL4 4.07-+0.16 18.10-+ 1.13 n.d. 
Tyrosine hydroxylase (TH) activity was determined using the 14CO2 
assay and dopa oxidase (DO) activity was measured using the continuous 
MBTH assay. Specific activities are expressed per mg of protein. The 
amount of membrane-bound tyrosinase protein was determined by laser 
densitometer scanning of Western blots probed with antibody aPEP7. 
Data represent mean_+ S.D. for three determinations. 
A.U., absorbance units 
n.d., not determined. 
3.2. Physiology of pigment synthesis 
Pigmentation of c + b subclones increases ignificantly 
when the culture medium is not changed for several days. 
To investigate whether this increase in pigmentation corre- 
lates with alterations in tyrosinase activity and/or expres- 
sion of the b-protein, cells were seeded at a fixed density 
and pigmentation, cell number, and tyrosinase activity 
were measured over a time course during which the medium 
was not renewed (Fig. 2). The growth of double transfec- 
tant subclone c + b~.~ was compared to that of clone c 
which expresses only tyrosinase, and to subclone b2. 2 
which expresses the b-protein alone [12]. 
The growth curve for subclone b2. ~ (Fig. 2A) is virtu- 
ally identical to that of untransfected 3T3 Swiss fibroblasts 
(data not shown), and clone c grows slightly more slowly. 
In contrast, subclone c + b~.2 cells grow poorly when the 
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Fig. 2. Effect of cell density on tyrosinase activity, pigmentation and b-protein levels of transfected fibroblasts. Cells were seeded at a fixed density and 
measurements of (A) viable cell number, (B) pigmentation, (C) dopa oxidase activity, and (D) b-protein level, were made over a time course. Cell lines are 
(O)  clone c expressing tyrosinase alone, (×)  subclone b2. 2 expressing the b-protein alone, and (O) subclone c + b l. 2 expressing both tyrosinase and the 
b-protein. Medium was not changed uring the experiment. Values for cell numbers and tyrosinase activity are the means for three samples 4- S.D. Error 
bars not shown are smaller than the symbols. Pigmentation values are estimated from observation of three pellets. For analysis of b-protein levels, cell 
extracts (80 /xg protein) were separated by SDS-PAGE under non-reducing conditions, blotted to nitrocellulose and probed with antibody TA99 followed 
by second antibodies labelled with 1251 for subclone c + bl. 2 or conjugated to HRP for subclone b2. 2. 
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culture medium is not changed regularly (Fig. 2A). For all 
three cell lines there is little difference between total and 
viable cell numbers throughout the time course (data not 
shown), and hence it appears that the low viable cell 
numbers for subclone c + b~. 2 reflect a failure to multiply. 
When the medium is changed at 48-h intervals, growth of 
subclone c + bl. 2 is virtually identical to that of subclone 
b2. 2 and clone c, all lines reaching a saturation density of 
7-9 × 10 6 viable cells per 125 cm 2 flask (data not shown). 
Pigmentation of both tyrosinase-expressing l es clone c 
and subclone c + bL2 decreases 24 h after seeding (Fig. 
2B). This is not due to cell multiplication (Fig. 2A), but 
may be due to changes induced in the cells by subculturing 
procedures. Pigmentation of both lines increases over the 
remainder of the time course, and subclone c + bl. 2 is 
considerably darker than clone c by day 6 (Fig. 2B). 
Subclone b2. 2 remains unpigmented throughout the time 
course. The tyrosinase activity of both clone c and sub- 
clone c + b~. 2 increases in parallel to pigmentation (Fig. 
2C) which is expected since tyrosinase is the rate-limiting 
enzyme for melanin synthesis. At no stage of the time 
course could tyrosinase activity be detected in subclone 
b2.2. 
When the culture medium is changed at 48-h intervals, 
pigmentation of both clone c and subclone c + bL2 on day 
6 is the same as on day 0, and an increase in tyrosinase 
activity over the time course is not observed (data not 
shown). This suggests that when the medium is not re- 
newed, accumulation of metabolites may induce the in- 
crease in tyrosinase activity and pigmentation of these 
lines. 
The amount of b-protein was measured over the same 
time course by quantifying the protein detected on Western 
blots with antibody TA99 (Fig. 2D). In subclone c + bL2 
the amount of b-protein increases in parallel to tyrosinase 
activity, both reaching a maximum on day 6: tyrosinase 
activity increases 9-fold and the amount of b-protein 6-fold 
between days 1 and 6 (Fig. 2C,D). In contrast, in subclone 
b2. 2 the amount of b-protein reaches a maximum on day 2 
then decreases, returning to its original evel by day 6 (Fig. 
2D). This difference in b-protein kinetics suggests that the 
presence of tyrosinase may influence the steady-state l vel 
of the b-protein. 
3.3. Enzyme activities of double transfectants 
Assays for tyrosinase in extracts of confluent cultures 
showed that double transfectants expressing the b-protein 
have between 3-and 7-fold higher activity than clone c 
(Table 1 and data not shown). In contrast, c-hyg subclones 
derived by transfection of clone c with the hygromycin-re- 
sistance plasmid alone, have approximately equal or 
slightly lower tyrosinase activity than clone c (data not 
shown). The enhanced tyrosinase activity of c + b sub- 
clones applies to both tyrosine hydroxylase (TH) and dopa 
oxidase (DO) activities. T]he DO/TH ratios for several 
c + b subclones are not significantly different (P  > 0.1) 
from the ratio for clone c (data not shown), confirming that 
the enhancement of tyrosinase activity affects both func- 
tions of the enzyme qually. For a given cell line, the ratio 
of enzyme activity to tyrosinase protein is constant, but the 
relative amount of tyrosinase protein in clone c and c + b 
subclones does not correlate completely with their relative 
enzyme activity (Table 1 and data not shown). For exam- 
ple, the tyrosinase activity of subclone c + bLl is approxi- 
mately 7-fold that of clone c, but the amount of tyrosinase 
protein is only approximately 3-fold greater. Hence, the 
enhanced tyrosinase activity of c + b subclones cannot be 
completely accounted for by a higher steady-state l vel of 
tyrosinase protein. 
In melanocytes, tyrosinase xists in both membrane- 
bound and soluble forms, the soluble form being produced 
by proteolytic leavage of the membrane-bound enzyme 
close to the C-terminus [41,50]. In clone c, 60-70% of 
tyrosinase activity is found to be soluble after cellular 
fractionation [19], whereas only 40-50% of the enzyme 
from subclone c + b~. 2 is soluble. It is known that tyrosi- 
nase is released from living melanoma cells [51], and to 
further investigate the processing of the enzyme in trans- 
fected fibroblasts we analysed culture medium for the 
presence of tyrosinase activity. Cells were seeded at a 
fixed density and activity was measured over a time course 
of four days during which the medium was not changed. 
At all time points, the level of tyrosinase activity in the 
medium from clone c was higher than in the medium from 
subclone c + bl. 2 (Fig. 3). Due to the slower multiplication 
of subclone c + bl. 2, the number of clone c cells per flask 
is 1.5-to 2-fold that of subclone c + bl. 2 cells over much of 
the time course, but this is counterbalanced by the fact that 
the specific tyrosinase activity of subclone c + bl. 2 is 2-to 
3-fold greater (Fig. 2). Hence, the 2-to 5-fold higher 
enzyme activity in medium from clone c suggests that this 
cell line releases proportionately more tyrosinase. Interac- 
E 
7 
.- 10 
E 
~ 0" . . . .  t 
Fig. 3. Comparison of tyrosinase activity in the culture medium of clone c 
and subclone c+bt.  2. Cell lines are (©) clone c expressing tyrosinase 
alone, and (O) subclone c+bl .  2 expressing both tyrosinase and the 
b-protein. Cells were seeded at a fixed density and media samples 
prepared by method D over a time course. Medium was not changed 
during the experiment. Tyrosinase activity was assayed by the method of 
Witthjer et al. [41] and values are expressed per ml culture medium. 
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tion of the b-protein with tyrosinase in some form of high 
molecular weight complex [17,18] may explain the in- 
creased amount of tyrosinase in the membrane-bound frac- 
tion of subclone c + bin, and the decreased release of 
enzyme to the medium. 
The distribution of the b-protein between membrane- 
bound and soluble fractions in subclone c + bl. 2 was  anal- 
ysed by Western blotting using antibody TA99 (data not 
shown). More than 95% of the b-protein is membrane- 
bound, as is the case in human melanoma cells [52], and 
hence we assume that the b-protein interacts primarily with 
membrane-bound tyrosinase rather than the soluble form 
of the enzyme. 
We recently reported that the b-protein functions as a 
stereospecific L-dopachrome tautomerase [12], and hence 
tested for this activity in c + b subclones. In common with 
other cell types, c + b subclones possess a high level of 
D-dopachrome tautomerase activity which does not bind to 
Con A-Sepharose and produces DHI [53]. However, c + b 
subclones also contain a dopachrome tautomerase activity 
which binds to Con A-Sepharose and catalyses the conver- 
sion of L- but not o-dopachrome to DHICA. For subclone 
C q-bl .  2 the specific activity of the L-dopachrome tan- 
tomerase is approximately 0.9 nmol min- 1 per mg of Con 
A-purified protein. This L-dopachrome tautomerase is pre- 
sent in fibroblasts expressing the b-protein alone at a 
similar level, but not in untransfected fibroblasts or clone c 
[12]. The finding of activity in c + b lines is consistent 
with our previous proposal that the b-protein functions as 
an L-dopachrome tautomerase [12]. 
3.4. Characterisation of the pigment synthesised by double 
transfectants 
Clone c expresses tyrosinase and contains the melanin 
synthesis intermediates L-dopa, 5-S-cysteinyldopa and 5- 
S-glutathionyldopa. It produces a phaeomelanin-like pig- 
ment, but does not contain detectable umelanin [19]. 
Fibroblasts expressing both tyrosinase and the b-protein 
are more darkly pigmented than clone c, and we tested 
whether this change in colour correlates with alterations in 
the levels of melanin intermediates and in the nature of the 
melanin polymer. 
Table 2 
Catechol levels in extracts of fibroblasts expressing tyrosinase alone 
(clone c) or tyrosinase and the b-protein (subclone c +bl. 4) 
Cell line Compound concn. (nmol/mg protein) 
L-dopa 5-S-CD 5-S-GD 5-S-CGD 
Clone c 0.03 1.40 0.23 0.00 
Subclone c+bE4 0.14 8.60 5.85 0.10 
Catechol content of cell extracts prepared from confluent cultures was 
measured as described in Section 2. The results of a typical experiment 
are shown. Similar results were obtained each time. 
Table 3 
Melanin synthesis ntermediates in culture medium of fibroblasts express- 
ing tyrosinase alone (clone c) or tyrosinase and the b-protein (subclone 
C q-bl. 4 ) 
Cell line 5-S-CD conch. 6H5MI2CA concn. 
(/xmol ml- i ) (/xmol ml- I ) 
day 1 day 4 day 1 day 4 
Clone c 0.02 0.46 0.00 0.01 
Subclone c+ b l. 4 0.01 0.57 0.00 0.55 
Cells were seeded at a density of 2;< 106 per 25 cm z flask on day 0 and 
media samples were prepared over a time course. Levels of melanin 
intermediates were determined as described in Section 2 and are ex- 
pressed per ml of culture medium. The results for one of three experi- 
ments are shown. Similar results were obtained each time. 
The amounts of the melanin synthesis intermediates 
L-dopa, 5-S-cysteinyldopa and 5-S-glutathionyldopa are all 
considerably higher in extracts of subclone c + bl. 4 than in 
clone c (Table 2): the levels of L-dopa and 5-S- 
cysteinyldopa re approximately 5-fold greater and the 
level of 5-S-glutathionyldopa is 25-fold higher. We were 
also able to detect 5-S-cysteinylglycinedopa in subclone 
c + bl.4, but this compound was not present at a detectable 
level in clone c. It is formed on the hydrolysis of 5-S- 
glutathionyldopa by the enzyme 7-glutamyl transpeptidase 
[54]. The higher levels of melanin intermediates in sub- 
clone c + bl. 4 suggest hat the tyrosinase activity of this 
line is greater than that of clone c in vivo as well as in 
vitro (Tables 1 and 2). 
5-S-Cysteinyldopa in the culture medium from clone c 
and subclone c + bl. 4 was analysed over a time course 
during which the medium was not changed. The level 
increases over the time course and is similar in the two 
lines at all time-points (Table 3). The ratio of concentra- 
tions of 5-S-cysteinyldopa in the medium compared to cell 
extracts is higher for clone c than for subclone c + bl.4, 
even when the slower growth of subclone c + bl. 4 is taken 
into account (Tables 2 and 3). No melanin intermediates 
were detectable in cell extracts or medium from untrans- 
fected fibroblasts or fibroblasts expressing the b-protein 
alone. 
Analysis of medium from subclone c + bl. 4 also re- 
vealed the presence of several carboxylated indoles: 
DHICA, 5-hydroxy-6-methoxyindole-2-carboxylic acid 
(5H6MI2CA) and 6-hydroxy-5-methoxyindole-2-carbo- 
xylic acid (6H5MI2CA) (Fig. 4A). None of these com- 
pounds were detectable in medium from clone c. We 
quantitated the amount of 6H5MI2CA in the medium by 
comparison with a synthetic standard (Fig. 4B) over a time 
course of four days during which the medium was not 
changed. 6H5MI2CA was not found at levels significantly 
above background in medium from clone c at any time- 
point, but increased markedly by day four in medium from 
subclone c + bl. 4 (Table 3). Carboxylated indoles are only 
expected to be predominant in cells containing an active 
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Fig. 4. HPLC analysis of carboxylated indoles in the culture medium of 
fibroblasts co-expressing tyrosinase and the b-protein. (A) A representa- 
tive sample of culture medium from subclone c+bL2, grown for 4 days 
without he medium being changed, was analysed by HPLC as described 
in Section 2. Retention times for carboxylated indoles are: (1) DHICA, 
3.63 min; (2) 5H6MI2CA, 7.21 rain; (3) 6H5MI2CA, 11.67 min. (B) 
Trace for a synthetic 6H5MI2CA standard used for quantifying this 
carboxylated indole. 
L-dopachrome tautomerase ince spontaneous oxidation of 
the L-dopachrome produced by tyrosinase generates decar- 
boxylated products. Hence, these results suggest hat the 
b-protein acts as a dopachrome tautomerase in vivo as well 
as in vitro [12]. 
Clone c synthesises a phaeomelanic pigment and its 
hydrolysis product AHP is present at a concentration of
0.15-0.19/zg per mg of protein [19]. The yield of AHP is 
0.72 /zg per mg of protein for subclone c + bl.4, indicating 
that these cells contain 3--4 times more phaeomelanic 
pigment han clone c. 
The eumelanin degradation product PTCA is produced 
in very low yield on oxidation with potassium perman- 
ganate, limiting the sensitivity of the assay for this form of 
melanin. No PTCA could be: detected on analysis of clone 
c, but trace amounts were detected in hydrolysates of 
subclone c + bl.  4. 
On oxidation with potas,;ium permanganate, TDCA is 
produced from phaeomelanin, and hence the ratio of TDCA 
to PTCA can be used to judge the ratio of phaeomelanin to 
eumelanin [49]. This ratio 'was estimated to be approxi- 
mately 4 to 1 for subclone c + bL4. 
4. Discussion 
4.1. Interaction of tyrosinase and the b-protein 
On transfection of clone c with a b-protein expression 
vector, we observed that fibroblasts expressing both tyrosi- 
nase and the b-protein have higher tyrosinase activity than 
the parent line that expresses tyrosinase alone. Although 
all double transfectant lines described in this report were 
derived from the same parent line, clone c, we have 
observed a similar increase in tyrosinase activity when 
several other tyrosinase-expressing l es were transfected 
with the b-protein (Winder, A.J., unpublished ata), and 
believe the results reported here to be generally applicable. 
The higher in vitro tyrosinase activity of c + b subclones 
correlates with increased levels of the melanin intermedi- 
ates dopa, 5-S-cysteinyldopa and 5-S-glutathionyldopa in 
cell extracts, demonstrating that enzyme activity is also 
greater in vivo. We have previously shown that the higher 
tyrosinase activity of c + b suclones is not due to rear- 
rangement of the transfected tyrosinase cDNA or to alter- 
ations in transcription of this sequence [55]. The increased 
enzyme activity results primarily from a higher steady-state 
level of tyrosinase protein which in turn is due to stabilisa- 
tion by interaction with the b-protein [55]. However, data 
presented in this report suggest hat an increased level of 
tyrosinase protein cannot completely account for the mea- 
sured increase in enzyme activity, implying that presence 
of the b-protein may also activate the enzyme. In addition, 
a comparison of kinetics of accumulation of the b-protein 
in fibroblasts expressing this protein alone, or in combina- 
tion with tyrosinase, suggests that the presence of tyrosi- 
nase influences the steady-state level of the b-protein. 
Tyrosinase and the b-protein co-localise in lysosomes in 
c + b subclones [55] and a large proportion of both pro- 
teins are membrane-bound i  double transfectants, favour- 
ing the concept hat the two proteins interact in a mem- 
brane-bound complex, as has been previously reported to 
be the case in melanoma cells [17,18]. In melanocytes, 
tyrosinase and the b-protein are located in melanosomes, 
and recent evidence suggests that these organelles are 
closely related to lysosomes [ 12,17,20]. 
4.2. The b-protein acts as a dopachrome tautomerase in
vivo 
Conversion of the light brown phenotype of fibroblasts 
expressing tyrosinase alone to dark brown on co-expres- 
sion of the b-protein suggests that the expressed b-protein 
is functional. There has been considerable controversy 
regarding the function of the b-protein, proposals having 
been made that it acts as a second tyrosinase, a catalase, a
dopachrome tautomerase or a DHICA oxidase 
[6,7,12,28,29]. Our previous tudies of fibroblasts express- 
ing the b-protein alone showed that this protein can act as 
an L-specific dopachrome tautomerase [12], but due to the 
presence of high D-dopachrome tautomerase activity in cell 
extracts [53] we were only able to demonstrate his func- 
tion in fractions enriched in the b-protein by Con A-Sep- 
harose chromatography. This Con A-binding L-dopach- 
rome tautomerase activity is present in fibroblasts co-ex- 
pressing tyrosinase and the b-protein, but not in fibroblasts 
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expressing tyrosinase alone, providing additional evidence 
that the b-protein has this function. 
In the absence of dopachrome tautomerase, spontaneous 
oxidation of L-dopachrome generated by tyrosinase pro- 
duces predominantly decarboxylated indoles which are 
very unstable and cannot be detected in culture medium. 
The presence of carboxylated indoles in the medium of 
c + b subclones therefore strongly suggests that these cells 
contain an L-dopachrome tautomerase enzyme. No carbox- 
ylated indoles are found in the medium from clone c, even 
though the tyrosinase product 5-S-cysteinyldopa is readily 
detectable, and hence it appears that the b-protein acts as 
an L-dopachrome tautomerase in vivo as well as in vitro. 
This does not, however, rule out the possibility that the 
b-protein may also have other enzyme activities, as has 
been demonstrated for tyrosinase [30,31]. Furthermore, it 
should be borne in mind that the mechanism of conversion 
of dopachrome toDHICA is a matter of debate [26,56-58], 
and further work is needed to define the precise catalytic 
activity of the b-protein with respect o dopachrome tau- 
tomerisation. 
4.3. Fibroblasts co-expressing tyrosinase and the b-protein 
synthesise both eumelanin and phaeomelanin 
Detection of higher levels of phaeomelanin and traces 
of eumelanin in c + b subclones is consistent with the 
darker phenotype of these cells compared to clone c in 
which only low levels of phaeomelanin are detected [19]. It 
has been proposed that the switch between the synthesis of 
eumelanin and phaeomelanin is controlled by the level of 
tyrosinase activity and that eumelanin is only produced 
when the level of tyrosinase activity is high enough to 
saturate the supply of thiols [21,59]. The higher in vitro 
tyrosinase activity of c + b subclones compared to clone c, 
and the higher levels of intermediates within the cells, are 
consistent with this hypothesis. 
Del Marmol et al. [60] recently reported a correlation 
between expression of b-protein mRNA and synthesis of 
eumelanin in melanoma cells and concluded that the b-pro- 
tein is involved only in eumelanin and not in phaeome- 
lanin synthesis. However, no data on protein levels were 
presented, and our results suggest hat the situation is not 
quite so straightforward, presence of the b-protein having 
at least two effects. Firstly, its presence results in higher 
tyrosinase activity which in turn leads to the synthesis of 
increased amounts of phaeomelanin, and formation of 
eumelanin when the supply of thiols is saturated. Sec- 
ondly, presence of L-dopachrome tautomerase activity will 
affect eumelanin synthesis since the ratio of DHI to DHICA 
is important in determining both the rate of melanin forma- 
tion and the nature of the pigment [18,61]. A high level of 
dopachrome tautomerase activity relative to tyrosinase ac- 
celerates melanin synthesis and results in the formation of 
a more ordered polymer [61], and DHICA has itself been 
shown to be incorporated into mammalian melanins [62]. 
4.4. The b-protein may have a protective role 
Growth of c + b subclones is strongly inhibited when 
the culture medium is not renewed regularly, although the 
majority of cells remain viable. Fibroblasts expressing the 
b-protein alone have similar growth kinetics to untrans- 
fected cells, whereas clone c, expressing tyrosinase at a 
low level, grows slightly more slowly. The strong inhibi- 
tion of growth of c + b subclones is therefore very likely 
to be related to the high tyrosinase activity of these lines. 
Increased tyrosinase activity results in elevated intra- 
cellular levels of cytotoxic melanin intermediates and the 
depletion of thiols, particularly glutathione. In c + b sub- 
clones the level of 5-S-glutathionyldopa, formed by non- 
specific oxidation of L-dopa in the cytoplasm, is much 
higher than that found in melanoma cells such as IGR 1 
[59]. Its formation probably reflects the lack of true 
melanosomes which normally retain the highly-reactive 
quinones produced uring melanin synthesis. Considerable 
oxidative stress is induced by the generation of cytotoxic 
melanin intermediates, and by the production of hydrogen 
peroxide in the medium on their extracellular oxidation 
[54,63]. 
Indirect evidence suggests that presence of the b-protein 
is necessary for the survival of fibroblasts with high 
tyrosinase activity, since attempts to increase the tyrosi- 
nase activity of clone c by re-transfection with a second 
tyrosinase xpression vector have failed to produce any 
clones with significantly higher enzyme activity (Winder, 
A.J., unpublished ata). This suggests that in fibroblasts 
expressing tyrosinase alone there is a maximum level of 
enzyme activity compatible with survival, but that when 
the b-protein is co-expressed with tyrosinase, transfected 
fibroblasts can survive with up to 7-fold higher tyrosinase 
activity. This protective function of the b-protein may be 
related to its dopachrome tautomerase activity, since 
DHICA, the product of L-dopachrome tautomerase, is much 
less cytotoxic than the spontaneous oxidation product DHI 
[11,18]. 
4.5. Interactions of  other melanogenic proteins 
Co-expression of tyrosinase and the b-protein in fibro- 
blasts has provided insight into the functions and interac- 
tions of these two proteins and their roles in melanin 
synthesis. Following the recent cloning of cDNAs encod- 
ing other proteins involved in regulating melanin synthesis, 
it will be useful to extend this co-expression approach to 
build up a picture of how multiple melanogenic proteins 
interact. Fibroblast expression studies may also prove use- 
ful in relating specific mutations in melanogenic proteins 
to phenotypic effects. The limitations of using fibroblasts 
to study proteins normally synthesised by cells of a differ- 
ent lineage must always be borne in mind. In particular, 
lack of true melanosomes may limit the usefulness of this 
system, but given recent evidence of the close relationship 
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between melanosomes and lysosomes, in which melanin is 
synthesised in transfected fibroblasts [12,17,20], this may 
not be the case. 
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